Clinical Trial: Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma
Sponsor and Collaborators
Singapore General Hospital
Contact: Daryl Tan, MBBS MRCP
Contact: Pei Woon ZN Eng, Bsc (hons)
Daryl Tan, MBBS MRCP Singapore General Hospital
Next post in Lymphoma Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.